Background: AIDS patients are at increased risk of developing concurrent infections with viral, parasitic, fungal or mycobacterial organisms. They can present constitutional symptoms of fever and weight loss, either due to infections or an underlying lymphoma which may coexist. Case report: A child with HIV-AIDS and mild encephalopathy is reported, who during the course of a confirmed disseminated mycobacterial disease developed neurological impairment. Post-mortem examination revealed disseminated BCG infection and Epstein-Barr associated primary CNS lymphoma. Epstein-Barr virus (EBV) presence was assessed by LMP-1 protein labelling by immunohistochemistry and in situ hybridisation (ISH) for Epstein-Barr virus-encoded RNAs (EBERs) in formalin-fixed and paraffin-embedded sections. Conclusions: BCG vaccination among HIV-1 infected children leads to the risk of disseminated BCG infection. BCG immunization programmes should be reconsidered for children at risk of HIV infection, because the risk of delayed complications is independent of the immunological status at the time of the vaccination.
Introduction
Human immunodeficiency virus infection produces a broad spectrum of diseases in both children and adults. AIDS patients are at increased risk of developing opportunistic infections. Patients may present symptoms of fever and weight loss, either due to infections or a coexisting lymphoma. In children, opportunistic, reactivated latent infection and CNS lymphoma have been infrequent according to neuroradiological and autopsy examination. The most frequent CNS complication is progressive encephalopathy attributable to primary HIV infection of the brain. 1 Primary CNS lymphoma represents a frequent complication of HIV infection in adults, occurring in as many as 6-10% of patients with AIDS, however, only isolated cases of primary CNS lymphoma occurring in HIV-infected children have been reported, [2] [3] [4] [5] and a striking association with Epstein-Barr virus (EBV) infection has been demonstrated. [5] [6] [7] Disseminated infection by bacillus Calmette-Guérin (BCG) is a rare but severe complication of BCG vaccination in immunodeficient patients. There is an increasing number of reports on this topic. Local or disseminated BCG disease has historically been a disease of infants, but cases in adults and older children with AIDS have been reported. 8, 9 A case is reported here of a child with AIDS with a mild HIV encephalopathy, who during the course of confirmed disseminated mycobacterial disease developed neurological impairment. Post-mortem examination revealed disseminated BCG infection and Epstein-Barr virus associated primary CNS lymphoma.
Material and methods

Immunohistochemistry (IHC)
The detection of latent membrane protein-1 (LMP-1) of EBV was performed using a pool of four monoclonal antibodies (MoAbs) CS1-4 (Dako Corporation, Carpinteria, CA, USA). Immunohistochemical characterization of the lymphoma was performed using antibodies to CD20 (L26), CD3 (PS1) (BioGenex, San Ramon, CA, USA) CD30 (Ber-H2), CD15 (Leu-M1) and CD68 (PG-M1) (Dako Corporation, Carpinteria, CA, USA). Immunohistochemical detection on formalin fixed paraffin embedded tissues employed the streptavidin-biotin complex with horseradish peroxidase technique according to the manufacturer's instructions (Dako Corporation, CA, USA).
In situ hybridization (ISH)
Fluorescein isothiocyanate (FITC)-conjugated Epstein-Barr encoded RNA (EBERs) oligonucleotides were used as probes for the hybridization procedure on paraffin sections. EBERs ISH was performed as previously described by Preciado et al. 10 Detection of the hybridized sites was achieved using a monoclonal antibody anti-FITC labelled with alkaline phosphatase (Novocastra, Newcastle-upon-Tyne, UK), performed according to the manufacturer's instructions.
Polymerase chain reaction assay for Mycobacterium tuberculosis
Preparation of DNA: Samples submitted were sputum, CSF and blood. Sputum was decontaminated and digested by the NALC-NaOH method. 11 CSF was concentrated by centrifugation. Both samples were then treated with proteinase K. Peripheral blood mononuclear cells were separated and DNA was obtained.
PCR: Amplification of DNA was designed as nested-PCR using the oligonucleotides described by Eisenach and Nolte as primers IS-1 (884-865), IS-2 (568-588) and IS-3 (762-781). 12, 13 Primer IS-4 (910-891) was personally selected from the complete sequence published by Eisenach. The amplified region (123 bp) belongs to the IS6110 repeated sequence which is specific for Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis, M. africanum and M. microti). 11, 12 Both PCRs were performed in a final volume of 50 ml containing 1.5 mM MgCl 2 ; 200 mM (each) dNTPs; 0.5 mM (each) primers; 1.25 U of Taq DNA polymerase; 1Â PCR buffer provided with the enzyme, and 5 ml of DNA or 20 ml of lysis supernatant. The reaction was made in a touchdown system from 70 8C to 68 8C for the first round (IS-2-IS-4) and 74 8C to 68 8C for the second (IS-1-IS-3). Inhibition was also evaluated.
The following biochemical characteristics were used to identify M. bovis-BCG: negative niacin test;
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Case report
A 30-month-old girl with AIDS was admitted to the Hospital de Niños 'Ricardo Gutiérrez' in Buenos Aires due to diarrhea and dehydration. Perinatally-acquired HIV infection was diagnosed at three months of age. Her clinical history included Pneumocystis carinii pneumonia, recurrent oral candidiasis, chronic diarrhea and bacterial pneumonia. By 12 months of age she had neurodevelopmental delay, hyperreflexia and a CT scan showed cerebral atrophy. She had received BCG vaccine in her first month of life. She was treated with different antiretroviral protocols because of clinical, immunological and virological progression. A month prior to admission she had been studied because fever and a chest X-ray showed persistent atelectasia of the right upper lobe and mild diffuse interstitial pulmonary infiltrates without respiratory impairment. Twenty units of PPD administered intradermally was negative. Mycobacterium tuberculosis complex DNA was detected by PCR in the blood, and therapy was started with isoniazid, ethambutol, pyrazinamide and amikacin.
She had no known exposure to adults with tuberculosis. Multiple studies failed to demonstrate TB in her household contacts.
On admission she had diarrhea, fever and severe dehydration, oral thrush, mild hepatosplenomegaly and weight loss; her growth and development were delayed, she was alert and her mental status was not affected. She was on PCP prophylaxis with trimethoprim/sulphamethoxazole and antiretroviral therapy with stavudine, nevirapine and ritonavir. Her viral load was 5.8 log copies/ml, her CD4 was 1% (16 cells/mm 3 ) and CD8: 7% (112 cells/mm 3 ). Laboratory studies revealed a WBC of 2.8 Â 10 9 /L with 66% neutrophils, 26% lymphocytes, 5% monocytes and 3% eosinophils. Hemoglobin was 7.5 g/dl, platelets were 6.9 Â 10 9 /L and the erythrocyte sedimentation rate was raised (75 mm/h). Serum chemistry was normal.
Microsporidia diarrhea and urinary tract infection by Klebsiella pneumoniae were diagnosed and she required parenteral hydration and antibiotics.
A behavioral change was noticed with features of increasing apathy and decreasing willingness to speak, to walk or to eat at ten days after admission.
On the 20th hospital day a left pretibial lesion was observed. Radiographic examination showed an osteolytic lesion of the tibia and multiple osteolytic lesions in the long bones of the extremities. A 99 m TC methylenediphosphonic acid bone scan demonstrated increased uptake in multiple bones including upper and lower extremities and skull, at the blood pooling and late phases, compatible with osteomyelitis.
The tibial lesion was surgically drained. Histopathological examination of the bone revealed tuberculous osteomyelitits. In the smear of biopsy material over ten acid-fast bacilli per high power field were seen. Rifampin and clarithromycin were added to the previous scheme to give coverage for Mycobacterium tuberculosis, BCG bacillus and Mycobacterium avium-intracellulare complex. Bone cultures for bacteria or fungi were negative. Acid-fast stains of three separate samples of gastric fluid and sputum collected on different days were negative. PCR for the same samples was negative for Mycobacterium tuberculosis complex. Abdominal ultrasound examination showed only mild hepatomegaly.
A CT scan was performed, showing mild diffuse cortical atrophy. A high density lesion in the right internal capsule, a left-sided lesion that caused compression of the frontal horn and lateral ventricle with surrounding edema, and high density lesions in the basal ganglia, were seen (Figure 1) . A presumptive diagnosis of CNS tuberculosis was made. CSF examination was normal, the protein value was 27 g/dl and the glucose level 42 g/dl. No cells were seen. Gram and Ziehl-Nielsen staining were negative. PCR TB was negative. CSF and blood cultures were negative for bacteria, fungi and mycobacteria. The test for cryptococcal antigen was negative and serology for Toxoplasma gondii was also negative. A bone marrow aspirate disclosed no pathologic findings and culture was negative. Despite therapy there was no improvement during the following weeks.
The clinical condition worsened, with severe insomnia and extreme irritability. She experienced generalized seizures, nystagmus, compromize of her mental status, myoclonic jerking, hypertonia and hyperreflexia of all four limbs and neurogenic respiratory depression requiring respiratory assistance. Electroencephalography revealed diffuse slowing, but epileptiform activity was not detected. Funduscopic examination revealed no abnormalities.
Repeated CSF examination showed only a mild increase in protein level (67 g/dl). No cells were seen. A new CT scan revealed diffuse cortical atrophy with enlarged ventricles and decrease of lesion size in basal ganglia, with an enhanced diffuse zone in the right frontal lobe and in both occipital lobes. There were also low-density lesions in the internal capsule and in the anterior corpus callosum (Figure 2 ). Differential diagnoses included disseminated tuberculosis, primary HIV encephalopathy, toxoplas-mosis, CNS lymphoma or CNS fungal infection. A cerebral biopsy was planned but could not be done because the patient's clinical condition worsened. She died on the 71st hospital day. Post-mortem examination revealed a diffuse CNS lesion that involved brain parenchyma and bilateral ventricles, with multiple cystic lesions in the temporal lobules and a nodular lesion in the basal ganglia area. Histological examination disclosed atypical lymphoid cells with a predominant perivascular arrangement that involved cerebellum, brain stem and spinal cord (Figure 3 ). Large foci of ischaemic necrosis with calcifications and large intraparench-ymatous and intraventricular haemorrhage were found. No microorganisms were detected with PAS and Ziehl-Nielsen staining. Immunohistochemically, expressed B-cell antigen (CD20) and CD3, CD15, CD30, CD68 were negative. These results showed the diagnosis of this tumor to be a primary CNS diffuse large B cell lymphoma (Figure 4) .
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EBV results
EBERs in situ hybridization (ISH) showed intense nuclear labelling tending to spare the nucleolus. LMP-1 positive staining was detected in tumor cells localized to the cell membrane and cytoplasm ( Figure 5 ).
Discussion
This case showed a co-infection with three aggressive pathogens in one patient. The primary HIV infection, which progressed to AIDS, and a secondary infection of a disseminated BCG infection with the occurrence of an EBV-associated CNS lymphoma. This case emphasizes the need for invasive diagnostic methods to disclose concomitant etiologies. In this particular case, a brain biopsy could not be carried out because of the deep location of the lesion and the critical clinical status of the patient. Only post-mortem examination revealed the final diagnosis.
Disseminated BCG infection is a long-known entity with numerous reports published prior to the AIDS era, especially from European countries.
A French national retrospective study reported 0.59 cases of disseminated BCG infection/1 million vaccinated healthy children. 14 Lotte reported 2 cases/1 million with a mortality rate of 80%, in a retrospective study from six European countries. 15 Cellular immunodeficiency was identified as the chief risk factor for fatal outcome. 15, 16 Tuberculous osteitis is one of the most frequent complications of the BCG vaccination. 17, 18 In severe immunodeficiency, there is a lack of granuloma formation and unimpeded proliferation of acid-fast bacilli and variable or absent necrosis. 19, 20 Usually these patients have specific unresponsiveness to tuberculin tests. 21 The case here showed both histopathological findings, as there was necrosis in the osteal lesion, but it was absent in the spleen.
PCR led to the diagnosis of disseminated Mycobacterium tuberculosis complex infection one month before the beginning of bone symptoms in the reported patient. The sensitivity, specificity and positive predictive value of PCR when applied to pediatric samples for diagnosing tuberculosis are 78.4%, 96% and 97% respectively, 22 and no cross reaction with mycobacteria other than M. tuberculosis complex has been observed. 23, 24 In spite of some studies that report a small risk of complications following BCG vaccination among HIV-1 infected children and encouraged the benefits of BCG vaccination, 25, 26 there are several reports of severe, including fatal, disseminated BCG infection occurring in immunodeficient patients. 9, 27 Therefore, BCG immunization programmes should be reconsidered for children at risk of HIV infection. Immunocompromized patients with late-stage AIDS are at great risk, with an overall 71% mortality reported. 6, 28 Both this case, and similar cases reported, emphasize the hazards of BCG vaccination in HIV-infected infants. This is the first case of primary CNS lymphoma seen at the Hospital de Niños Ricardo Gutiérrez in Buenos Aires, Argentina, among 351 HIV-infected children followed up prospectively. 29 This represents a frequency lower than 1%, which is similar to the 1996 CDC report of 30 children with CNS lymphoma, among 7629 children with AIDS, which represented a frequency of 0.4%. In addition, the AIDS-Cancer Match Registry (July 2000) reported a frequency of 0.5%. 30, 31 Only a few cases of primary central nervous system NHL (non-Hodgkin's lymphoma) occurring in children with HIV infection have been reported so far. [2] [3] [4] [5] Other CNS NHL associated with EBV have not yet been reported in Argentina.
The Epstein-Barr virus may be responsible for the lymphoproliferative disorders described in HIV infected children. 32, 33 When EBV infects B-lymphocytes, it induces cell proliferation. Such lymphoproliferative action may enable oncogenesis by increasing the probability of genetic alterations (e.g. chromosomal translocations such as those seen in Burkitt lymphoma) and/or by expanding an already malignant clone. 7 Expression of LMP-1, an oncogenic protein, by tumor cells supports the involvement of EBV in disease pathogenesis. It is well known that primary CNS lymphoma occurs with increased frequency in adult patients with AIDS and they are nearly always EBV positive. 34 Like the case reported here, most patients died very soon after the time of onset of symptoms related to the lymphoma, suggesting the need of both rapid diagnostic procedures and treatment. Although the clinical outcome with current treatments remains rather discouraging, there have been some recent reports describing a more positive prognosis. 35, 36 
